On April 16, 2023, Tara Health Foundation announced that it has filed an exempt solicitation statement with Securities and Exchange Commission, requesting the shareholders of Pfizer Inc to vote for a proposal regarding publish an annual report, at reasonable expense, analyzing the congruency of political, lobbying, and electioneering expenditures during the preceding year against publicly stated company values and policies, including Company?s stated goal to end discrimination against women, ensure equal opportunities for leadership and access to reproductive health, at the 2024 annual meeting of shareholders.
Market Closed -
Other stock markets
|
Pre-market 09:25:08 am | |||
25.64 USD | +0.94% | 25.69 | +0.20% |
02:52pm | Sensodyne maker Haleon to shut UK factory with loss of 435 jobs | AN |
05:55am | Genmab, Pfizer Win US FDA Approval for Cervical Cancer Treatment | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.94% | 145B | |
+26.47% | 664B | |
+27.99% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.51% | 234B | |
+4.81% | 199B | |
-10.14% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Tara Health Foundation Files an Exempt Solicitation Statement with Securities and Exchange Commission